In my opinion, investors could be interested in the following three stocks, as they meet the criteria listed below:
- Their price-earnings ratios trade below 20.
- Their earnings and revenue, both on a per share basis, have improved over the past five years, while no losses were recorded during the observed period.
- These stocks have positive recommendation ratings among sell-side analysts on Wall Street.
HCA Healthcare Inc
The first stock investors could be interested in is HCA Healthcare Inc. (HCA, Financial), a Nashville, Tennessee-based provider of medical care services in the U.S. and the UK through 185 general, acute care, psychiatric and rehabilitation hospitals. The company also operates more than 140 freestanding surgery and endoscopy centers.
The company saw its trailing 12-month revenue per share rise by 10.6% and its trailing 12-month earnings per share (EPS) without non-recurring items (NRI) rise by nearly 17% over the past five years. The price-earnings ratio (16.47 as of Monday) increased by 0.6% on average every year over the years observed.
The stock was trading at around $220.34 per share at close on Monday for a market cap of $72.86 billion. Currently, the company does pay a quarterly cash dividend of 48 cents per common share for a forward dividend yield of 0.87% as of Monday.
GuruFocus assigned a financial strength rating of 4 out of 10 and a profitability rating of 9 out of 10 to the company.
Wall Street sell-side analysts recommend a median rating of overweight for this stock and an average target price of $225 per share.
SVB Financial Group
The second stock investors could be interested in is SVB Financial Group (SIVB, Financial), a Santa Clara, California-based provider of diversified financial services including various banking and financial products and services.
The company saw its trailing 12-month revenue per share increase by 23.6% while its trailing 12-month EPS without NRI increased by 33.6% every year over the past five years. The price-earnings ratio (19.58 as of Monday) has increased by less than 2% on average every year over the same time period observed.
The stock was trading at around $593.66 per share at close on Monday for a market cap of $32.24 billion and a 52-week range of $204.78 to $608.84. Currently, the company is not paying dividends.
GuruFocus assigned a score of 4 out of 10 to the company's financial strength rating and 6 out of 10 to its profitability rating.
Wall Street sell-side analysts recommend a median rating of overweight for this stock and an average target price of $624.63 per share.
PerkinElmer
The third stock investors could be interested in is PerkinElmer (PKI, Financial), a Waltham, Massachusetts-based provider of products and solutions for clinical diagnostic and life science research organizations worldwide.
The company saw its trailing 12-month revenue per share rise by 12.4% and its trailing 12-month EPS without NRI rise by 23.3% per year over the past five years. The price-earnings ratio (16.19 as of Monday) has declined by 0.2% during the years in question.
The stock was trading at around $154.57 per share at close on Monday for a market capitalization of $17.33 billion and a 52-week range of $102.81 to $162.7 Currently, the company pays a quarterly cash dividend of 7 cents per common share with the next distribution scheduled for payment on Aug. 6, which will be in line with the previous payment. Thus, the stock offers a forward dividend yield of 0.18% as of Monday.
GuruFocus assigned a score of 5 out of 10 to the company's financial strength rating and 8 out of 10 to its profitability rating.
Wall Street recommends a median rating of overweight for this stock and an average target price of $157.62 per share.
Disclosure: I have no positions in any securities mentioned.
